Evidence map›Paper›PMID 34479471›Full record

ArticleCellular & molecular biology letters2021

HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury.

Min Zhao, Shaoting Wang, Anna Zuo, Jiaxing Zhang, Weiheng Wen, Weiqiang Jiang, Hong Chen, Donghui Liang, Jia Sun, Ming Wang

Open access · goldAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 3 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 3 syntheses or guidelines pooled it, 194 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  13. Post‑translational modifications in diabetic kidney disease (Review).International journal of molecular medicine · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Min Zhao *Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Shaoting Wang *School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Anna Zuo *School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Jiaxing ZhangSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Weiheng WenZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Weiqiang JiangZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Hong ChenZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Donghui LiangZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Jia SunZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China. sunjia@smu.edu.cn.
Ming WangZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China. wming1999@126.com.ORCID http://orcid.org/0000-0002-3258-6961
Zhujiang Hospital · CNSouthern Medical University · CN

Funding

Innovation team of chronic kidney disease with integrated traditional Chinese and Western Medicine 2019KCXTD014Jiangsu Provincial Key Research and Development Program (CN) 2019B020230001National Natural Science Foundation of China 8197033477National Natural Science Foundation of China 82074207, 81774035Natural Science Foundation of Guangdong Province 1914050000846Natural Science Foundation of Guangdong Province 2021A1515011502Science and Technology Program of Guangzhou 201804010478The Research Project of the Guangdong Provincial Administration of Traditional Chinese Medicine 20201226
6 · The paper itself

Abstract

backgroundEndothelial cell (EC) injury accelerates the progression of diabetic macrovascular complications. Hypoxia is an important cause of EC injury. Hypoxia-inducible factor-1 alpha (HIF-1α) is an important hypoxia regulatory protein. Our previous studies showed that high-glucose and hypoxic conditions could upregulate HIF-1α expression and enhance EC inflammatory injury, independently of the nuclear factor kappa-B (NF-κB) pathway. However, it is not clear whether HIF-1α plays a role in vascular disease through epigenetic-related mechanisms.

methodsWe conducted gene expression analysis and molecular mechanistic studies in human umbilical vein endothelial cells (HUVECs) induced by hyperglycemia and hypoxia using RNA sequencing (RNA-seq) and small interfering HIF-1α (si-HIF-1α). We determined HIF-1α and Jumonji domain-containing protein 1 A (JMJD1A) expression by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot, analyzed inflammatory protein secretion in the cell supernatant by enzymelinked immunosorbent assay (ELISA), and assessed protein interaction between HIF-1α and JMJD1A by chromatin immunoprecipitation (Ch-IP). We used the Cell Counting Kit8 (CCK-8) assay to analyze cell viability, and assessed oxidative stress indicators by using a detection kit and flow cytometry.

resultsHigh glucose and hypoxia up-regulated HIF-1α expression, and down-regulated HIF-1α decreased the level of inflammation and oxidative stress in HUVECs. To determine the downstream pathways, we observed histone demethylases genes and related pathway by RNA-sEq. Among these, JMJD1A was the most upregulated gene in histone demethylases. Moreover, we observed that HIF-1α bound to the promoter of JMJD1A, and the ameliorative effects of si-HIF-1α on oxidative stress and inflammatory cytokines in high-glucose and hypoxia-induced HUVECs were reversed by JMJD1A overexpression. Furthermore, knockdown of JMJD1A decreased inflammatory and oxidative stress injury. To determine the JMJD1A-related factors, we conducted gene expression analysis on JMJD1A-knockdown HUVECs. We observed that downregulation of inflammation and the oxidative stress pathway were enriched and FOS and FOSB might be important protective transcription factors.

conclusionsThese findings provide novel evidence that the HIF-1α/JMJD1A signaling pathway is involved in inflammation and oxidative stress in HUVECs induced by high glucose and hypoxia. Also, this pathway might act as a novel regulator of oxidative stress and inflammatory-related events in response to diabetic vascular injury and thus contribute to the pathological progression of diabetes and vascular disease.

Indexed as

Cell ProliferationCell SurvivalHumansHuman Umbilical Vein Endothelial CellsHyperglycemiaHypoxiaHypoxia-Inducible Factor 1, alpha SubunitInflammationJumonji Domain-Containing Histone DemethylasesOxidative StressSignal TransductionVascular System InjuriesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitJumonji Domain-Containing Histone DemethylasesKDM3A protein, humanDiabetesEpigeneticsHypoxia-inducible factor-1 alphaVascular disease

Identifiers

PMID34479471
PMCPMC8414688
OpenAlexW3197476485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.